Prevalence and sociodemographic risk factors of chlamydia, gonorrhoea and syphilis: A national multicentre STI survey in New Caledonia, 2012

BMJ Open

Volumn 5, Issue 9, 2015, Pages

  Corsenac, Philippe ^a   Noël, Martine ^b   Rouchon, Bernard ^a   Hoy, Damian ^c   Roth, Adam ^c  

^a Direction des Affaires Sanitaires et Sociales de la Nouvelle Calédonie   (New Caledonia)

^b New Caledonia Health and Social Affairs Service   (New Caledonia)

^c SECRETARIAT OF THE PACIFIC COMMUNITY   (New Caledonia)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; ETHNIC GROUP; EUROPE; FEMALE; GENDER; GENERAL PRACTICE; GONORRHEA; HEALTH CARE; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANESIAN; MIDDLE AGED; MIXED INFECTION; MULTICENTER STUDY; NEISSERIA GONORRHOEAE; NEW CALEDONIA; PREVALENCE; PREVENTION AND CONTROL; REVIEW; RISK FACTOR; SCREENING; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; SYPHILIS; TREPONEMA PALLIDUM; UNITED STATES; ADOLESCENT; CHLAMYDIA INFECTIONS; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; SOCIOECONOMICS; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CROSS-SECTIONAL STUDIES; FEMALE; GONORRHEA; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW CALEDONIA; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; SYPHILIS; YOUNG ADULT;

EID: 84947765645     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-007691     Document Type: Review

References (38)

1. La Ruche G, Goulet V, Bouyssou A, et al. [Current epidemiology of bacterial STIs in France]. Presse Med 2013; 42(4 Pt 1): 432-9
2. Herida M, Michel A, Goulet V, et al. [Epidemiology of sexually transmitted infections in France]. Med Mal Infect 2005; 35: 281-9
3. Klavs I, Rodrigues LC, Wellings K, et al. Prevalence of genital Chlamydia trachomatis infection in the general population of Slovenia: serious gaps in control. Sex Transm Infect 2004; 80: 121-3
4. van Bergen J, Gotz HM, Richardus JH, et al. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation, and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect 2005; 81: 17-23
5. Adams EJ, Charlett A, Edmunds WJ, et al. Chlamydia trachomatis in the United Kingdom: a systematic review, and analysis of prevalence studies. Sex Transm Infect 2004; 80: 354-62
6. Fenton KA, Korovessis C, Johnson AM, et al. Sexual behaviour in Britain: reported sexually transmitted infections, and prevalent genital Chlamydia trachomatis infection. Lancet 2001; 358: 1851-4
7. Datta SD, Torrone E, Kruszon-Moran D, et al. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sex Transm Dis 2012; 39: 92-6
8. Torrone EA, Johnson RE, Tian LH, et al. Prevalence of Neisseria gonorrhoeae among persons 14 to 39 years of age, United States, 1999 to 2008. Sex Transm Dis 2013; 40: 202-5
9. Da Ros CT, Schmitt Cda S. Global epidemiology of sexually transmitted diseases. Asian J Androl 2008; 10: 110-14
10. Dupin N. [Sexually transmitted infections in France in 2009]. Rev Prat 2010; 60: 520-5
11. De Schryver A, Meheus A. Epidemiology of sexually transmitted diseases: the global picture. Bull World Health Organ 1990; 68: 639-54
12. Wozniak TM, Moore HA, MacIntyre CR. Epidemiology of sexually transmissible infections in New South Wales: are case notifications enough?. Commun Dis Intell 2013; 37: e407-e414
13. Goulet V, Laurent E, Semaille C. [Augmentation du dépistage et des diagnostics d?infections à Chlamydia trachomatis en France: analyse des données Rénachla (2007-2009)]. Bull Epidemiol Hebd 2011(26-27-28): 316-20
14. Nguyen E, Bouyssou A, Lassau F, et al. [Progression importante des infections à gonocoques en France: données des réseaux Rénago et RésIST au 31 décembre 2009]. Bull Epidemiol Hebd 2011(26-27-28): 301-4
15. Goulet V, de Barbeyrac B, Raherison S, et al. Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infect 2010; 86: 263-70
16. Santer M, Warner P, Wyke S, et al. Opportunistic screening for chlamydia infection in general practice: can we reach young women?. J Med Screen 2000; 7: 175-6
17. Pimenta JM, Catchpole M, Rogers PA, et al. Opportunistic screening for genital chlamydial infection. II: prevalence among healthcare attenders, outcome, and evaluation of positive cases. Sex Transm Infect 2003; 79: 22-7
18. DASSNC. Situation sanitaire en Nouvelle-Calédonie: Les infections sexuellement transmissibles I.2.2 Secondary Situation sanitaire en Nouvelle-Calédonie: Les infections sexuellement transmissibles I.2.2 2012. 2011. http://www.gouv.nc/portal/page/portal/dass/librairie/fichiers/21548006.PDF
19. SPC. Enquêtes de Surveillance de Deuxième Génération du VIH et autres IST et Comportements à risque en Nouvelle-Calédonie. Partie 2: Etude de la prévalence clinique des IST lors de la première consultation prénatale 2005-2006. Secondary Enquêtes de Surveillance de Deuxième Génération du VIH et autres IST et Comportements à risque en Nouvelle-Calédonie. Partie 2: Etude de la prévalence clinique des IST lors de la première consultation prénatale 2005-2006. 2007. http://www.spc.int/hiv/index2.php?. option=com-docman&task=doc-view&gid=207&Itemid=148
20. Cliffe SJ, Tabrizi S, Sullivan EA, et al. Chlamydia in the Pacific region, the silent epidemic. Sex Transm Dis 2008; 35: 801-6
21. Grulich AE, de Visser RO, Smith AM, et al. Sex in Australia: sexually transmissible infection, and blood-borne virus history in a representative sample of adults. Aust N Z J Public Health 2003; 27: 234-41
22. Johnston A, Fernando D, MacBride-Stewart G. Sexually transmitted infections in New Zealand in 2003. N Z Med J 2005; 118: U1347
23. Lewis D, Newton DC, Guy RJ, et al. The prevalence of Chlamydia trachomatis infection in Australia: a systematic review, and meta-Analysis. BMC Infect Dis 2012; 12: 113
24. Panaretto KS, Lee HM, Mitchell MR, et al. Prevalence of sexually transmitted infections in pregnant urban Aboriginal, and Torres Strait Islander women in northern Australia. Aust N Z J Obstet Gynaecol 2006; 46: 217-24
25. Sherwood J, Coughlan E. Prevention, and control of sexually transmitted infections in New Zealand. N Z Med J 2007; 120: U2487
26. Vallely A, Page A, Dias S, et al. The prevalence of sexually transmitted infections in Papua New Guinea: a systematic review, and meta-Analysis. PLoS ONE 2010; 5: e15586
27. Watkins RE, Mak DB, Giele CM, et al. Aboriginal, and non-Aboriginal sexually transmitted infections, and blood borne virus notification rates in Western Australia: using linked data to improve estimates. BMC Public Health 2013; 13: 404
28. Binnicker MJ. Which algorithm should be used to screen for syphilis?. Curr Opin Infect Dis 2012; 25: 79-85
29. Kamangar F, Islami F. Sample size calculation for epidemiologic studies: principles, and methods. Arch Iran Med 2013; 16: 295-300
30. Carlin JB, Hocking J. Design of cross-sectional surveys using cluster sampling: an overview with Australian case studies. Aust N Z J Public Health 1999; 23: 546-51
31. CALMAR 2. A new version of the CALMAR calibration adjustment program. Proceedings of the Statistics Canada Symposium; 2003
32. Balfe M, Brugha R, Oconnell E, et al. Men?s attitudes towards chlamydia screening: a narrative review. Sex Health 2012; 9: 120-30
33. Balfe M, Brugha R, O?Donovan D, et al. Young women?s decisions to accept chlamydia screening: influences of stigma, and doctor-patient interactions. BMC Public Health 2010; 10: 425
34. Corbeto EL, Gonzalez V, Lugo R, et al. Discordant prevalence of Chlamydia trachomatis in asymptomatic couples screened by two screening approaches. Int J STD AIDS 2015; 26: 27-32
35. Diemert DJ, Libman MD, Lebel P. Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG test for diagnosis of Neisseria gonorrhoeae infection in a low-prevalence population. J Clin Microbiol 2002; 40: 4056-9
36. Low N, McCarthy A, Macleod J, et al. Epidemiological, social, diagnostic, and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess 2007; 11: iii-iv, ix-xii, 1-165
37. Tabrizi SN, Unemo M, Limnios AE, et al. Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae, and other Neisseria species. J Clin Microbiol 2011; 49: 3610-15
38. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea, and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007; 147: 89-96